FDA Clears GlucoStabilizer™ Intravenous Insulin Dosing Software



Quick Links


Implementing Effective Glucose Control


ACE Consensus

Antecedent Hyperglycemia is Associated with an Increased Risk of Neutropenic Infections During Bone Marrow Transplantation

Rachel L. Derr, M.D., Ph.D., Victoria C. Hsiao, M.D., Ph.D.

Christopher D. Saudek, M.D.

(Diabetes Care Publish Ahead of Print, published online July 23, 2008)

 

In a BMT population highly susceptible to infection, there was a continuous positive association between mean antecedent glycemia and later infection risk, particularly in patients who received glucocorticoids while neutropenic. Tight glycemic control during BMT and glucocorticoid treatment may reduce infections.

 

Email us for a copy of this article.


Does glycemic status at admission

predict mortality in noncritically ill

hospitalized patients?

Shilpa Harish Jain and Rajesh Garg

(Nature Clinical Practice Endocrinology & Metabolism.
Publish Ahead of Print August 2008)

 

Hyperglycemic patients hospitalized as a result of acute medical conditions are prone to increased morbidity and mortality. In this Practice Point commentary, the authors suggest that newly detected hyperglycemia is an important predictor of mortality in this patient group. In addition, an HbA1c level of >6% identified patients at the highest risk of death. Efforts to control glycemia should, therefore, be focused on this group.  Unfortunately, optimal targets and treatment strategies for glycemic control in noncritically ill patients have not yet been determined. Tight glycemic control is associated with a potential risk of hypoglycemia; however, glucose levels within the normal range might result in improved outcomes. Furthermore, several studies suggest a direct beneficial effect of insulin therapy. Although the evidence is incomplete, it seems prudent to initiate insulin treatment whenever hyperglycemia is recognized in a hospitalized patient.

 

Email us for a copy of this article.


Dynamic Tight Glycemic Control During and After Cardiac Surgery Is
Effective, Feasible, and Safe

by  Patrick Lecomte, MD, et al

(Anesthesia & Analgesia 2008;107:51–8)

This study evaluated the safety and efficacy of a nurse-driven insulin protocol (the Aalst Glycemia Insulin Protocol) for achieving a target glucose level of 80–110 mg/dL during cardiac surgery and in the intensive care unit (ICU). 483 nondiabetics and 168 diabetics, scheduled for cardiac surgery with cardiopulmonary bypass, were included in this study. To anticipate rapid perioperative changes in insulin requirement and/or sensitivity during surgery,  a dynamic algorithm was developed.  The algorithm adjusts insulin dosage based on blood glucose level and the projected insulin sensitivity (e.g., reduced sensitivity during cardiopulmonary bypass and normalizing sensitivity after surgery). The Aalst Glycemia Insulin Protocol was effective for maintaining tight perioperative blood glucose control during cardiac surgery with minimal risk of  hypoglycemia.

Email us for a copy of this article.


GlUCOSE CONTROL REDUCES
POST-OP INFECTIONS

by Christina Frangou

(Anesthesiology News. July 2008)

 

Summarizes the research presented at the 128th annual meeting of the American Surgical Association on how surgical infection rates could be reduced nationwide if surgeons and operating room teams monitored and tightly controlled post-operative glucose levels in all elective and emergency surgical patients.

 

Click here to read this article.


Economic Benefits of Intensive Insulin Therapy in Critically Ill Patients: The TRIUMPH Project
by Archana R. Sadhu, et al.
 (Diabetes Care. 2008 May 20. [Epub ahead of print])

A clinical team focused on hyperglycemia management for ICU patients can be a valuable investment with significant economic benefits for hospitals.

 

Email us for a copy of this article.


A replicable method for blood glucose control in critically Ill patients
by Alan H. Morris, et al.
(Crit Care Med 2008; 36:1787–1795)

The 91% to 98% clinician compliance indicates eProtocol-insulin is an exportable instrument that can establish a replicable experimental method for clinical trials of blood glucose management in critically ill adults. Control of blood glucose was better with eProtocol-insulin than with a simple clinical guideline or a paper-based protocol.

 

Email us for a copy of this article.


Glucose control in critical illness using a web-based insulin dose calculator
by Shondipon K. Laha, et al.
(Med Eng Phys.
2008 May;30(4):478-82. Epub 2007 Jul 23.)

The web-based insulin calculator facilitates the dosing of insulin in critical care. The lack of diurnal blood glucose concentrations suggests that once daily estimation of blood glucose may be an acceptable method of monitoring blood glucose concentrations in critical care.

 

Email us for a copy of this article.


Medical Automation Systems and its affiliate company Medical Decisions Network are pleased to provide GlycemicControl.net, a dynamic website that we trust will serve as a central knowledge source (clearinghouse) of up-to-date information on advances in the aggressive treatment of hyperglycemia and diabetes in hospitalized patients - tight glycemic control.  We also provide links to web sites that offer a comprehensive list of information on glycemic control protocols, implementation and management of these protocols, data collection and reporting,  products designed to provide continuous glucose monitoring in the hospital with the view to improve patient care, and outcomes in the tight glycemic control environment.  We welcome your visit!
© 2008 Medical Automation Systems, Inc., Charlottesville, VA USA.  All rights reserved. Legal Notice.                                                                 Back to top